Skip to main content
SpringerLink
Log in

Disabled homolog 2 is required for migration and invasion of prostate cancer cells

  • Research Article
  • Published:
Frontiers of Medicine Aims and scope Submit manuscript

Abstract

Disabled homolog 2 (DAB2) is frequently deleted or epigenetically silenced in many human cancer cells. Therefore, DAB2 has always been regarded as a tumor suppressor gene. However, the role of DAB2 in tumor progression and metastasis remains unclear. In this study, DAB2 expression was upregulated along with human prostate cancer (PCa) progression. DAB2 overexpression or knockdown effects in LNCaP and PC3 cell lines were verified to address the biological functions of DAB2 in PCa progression and metastasis. LNCaP and PC3 cell lines were generated from human PCa cells with low and high metastatic potentials, respectively. The results showed that DAB2 shRNA knockdown can inhibit the migratory and invasive abilities of PC3 cells, as well as the tumorigenicity, whereas DAB2 overexpression enhanced LNCaP cell migration and invasion. Further investigation showed that DAB2 regulated the cell migration associated genes in PC3 cells, and the differential DAB2 expression between LNCaP and PC3 cells was partly regulated by histone 4 acetylation. Therefore, DAB2 may play an important role in PCa progression and metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61(2): 69–90

    Article  PubMed  Google Scholar 

  2. Jilg CA, Ketscher A, Metzger E, Hummel B, Willmann D, Rüsseler V, Drendel V, Imhof A, Jung M, Franz H, Hölz S, Krönig M, Müller JM, Schüle R. PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cells. Oncotarget 2014; 5(24): 12646–12664

    PubMed Central  PubMed  Google Scholar 

  3. Pulukuri SM, Gondi CS, Lakka SS, Jutla A, Estes N, Gujrati M, Rao JS. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. J Biol Chem 2005; 280(43): 36529–36540

    Article  CAS  PubMed  Google Scholar 

  4. Xie S, Xie Y, Zhang Y, Huang Q. Effects of miR-145 on the migration and invasion of prostate cancer PC3 cells by targeting DAB2. Hereditas (Beijing) (Yi Chuan) 2014; 36(1): 50–57 (in Chinese)

    Article  CAS  Google Scholar 

  5. Mok SC, Wong KK, Chan RK, Lau CC, Tsao SW, Knapp RC, Berkowitz RS. Molecular cloning of differentially expressed genes in human epithelial ovarian cancer. Gynecol Oncol 1994; 52(2): 247–252

    Article  CAS  PubMed  Google Scholar 

  6. Fu L, Rab A, Tang LP, Rowe SM, Bebok Z, Collawn JF. Dab2 is a key regulator of endocytosis and post-endocytic trafficking of the cystic fibrosis transmembrane conductance regulator. Biochem J 2012; 441(2): 633–643

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Moore R, Cai KQ, Tao W, Smith ER, Xu XX. Differential requirement for Dab2 in the development of embryonic and extra-embryonic tissues. BMC Dev Biol 2013; 13(1): 39

    Article  PubMed Central  PubMed  Google Scholar 

  8. Jiang Y, Luo W, Howe PH. Dab2 stabilizes Axin and attenuates Wnt/β-catenin signaling by preventing protein phosphatase 1 (PP1)-Axin interactions. Oncogene 2009; 28(33): 2999–3007

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Chaudhury A, Hussey GS, Ray PS, Jin G, Fox PL, Howe PH. TGF-β-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI. Nat Cell Biol 2010; 12(3): 286–293

    CAS  PubMed Central  PubMed  Google Scholar 

  10. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139(5): 871–890

    Article  CAS  PubMed  Google Scholar 

  11. Zhang Z, Chen Y, Tang J, Xie X. Frequent loss expression of dab2 and promotor hypermethylation in human cancers: a meta-analysis and systematic review. Pak J Med Sci 2014; 30(2): 432–437

    PubMed Central  PubMed  Google Scholar 

  12. Mok SC, Chan WY, Wong KK, Cheung KK, Lau CC, Ng SW, Baldini A, Colitti CV, Rock CO, Berkowitz RS. DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer. Oncogene 1998; 16(18): 2381–2387

    Article  CAS  PubMed  Google Scholar 

  13. Sheng Z, Sun W, Smith E, Cohen C, Sheng Z, Xu XX. Restoration of positioning control following disabled-2 expression in ovarian and breast tumor cells. Oncogene 2000; 19(42): 4847–4854

    Article  CAS  PubMed  Google Scholar 

  14. Chao A, Lin CY, Lee YS, Tsai CL, Wei PC, Hsueh S, Wu TI, Tsai CN, Wang CJ, Chao AS, Wang TH, Lai CH. Regulation of ovarian cancer progression by microRNA-187 through targeting disabled homolog-2. Oncogene 2012; 31(6): 764–775

    Article  CAS  PubMed  Google Scholar 

  15. Teckchandani A, Toida N, Goodchild J, Henderson C, Watts J, Wollscheid B, Cooper JA. Quantitative proteomics identifies a Dab2/integrin module regulating cell migration. J Cell Biol 2009; 186(1): 99–111

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Chetrit D, Ziv N, Ehrlich M. Dab2 regulates clathrin assembly and cell spreading. Biochem J 2009; 418(3): 701–715

    Article  CAS  PubMed  Google Scholar 

  17. Orlandini M, Nucciotti S, Galvagni F, Bardelli M, Rocchigiani M, Petraglia F, Oliviero S. Morphogenesis of human endothelial cells is inhibited by DAB2 via Src. FEBS Lett 2008; 582(17): 2542–2548

    Article  CAS  PubMed  Google Scholar 

  18. Zhang Y, Xie S, Zhou Y, Xie Y, Liu P, Sun M, Xiao H, Jin Y, Sun X, Chen Z, Huang Q, Chen S. H3K36 histone methyltransferase Setd2 is required for murine embryonic stem cell differentiation toward endoderm. Cell Reports 2014; 8(6): 1989–2002

    Article  CAS  PubMed  Google Scholar 

  19. Liu Y, Song N, Ren K, Meng S, Xie Y, Long Q, Chen X, Zhao X. Expression loss and revivification of RhoB gene in ovary carcinoma carcinogenesis and development. PLoS ONE 2013; 8(11): e78417

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Hanker LC, Karn T, Holtrich U, Graeser M, Becker S, Reinhard J, Ruckhäberle E, Gevensleben H, Rody A. Prognostic impact of fascin-1 (FSCN1) in epithelial ovarian cancer. Anticancer Res 2013; 33(2): 371–377

    PubMed  Google Scholar 

  21. Fuse M, Nohata N, Kojima S, Sakamoto S, Chiyomaru T, Kawakami K, Enokida H, Nakagawa M, Naya Y, Ichikawa T, Seki N. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1. Int J Oncol 2011; 38(4): 1093–1101

    CAS  PubMed  Google Scholar 

  22. Fu H, Wen JF, Hu ZL, Luo GQ, Ren HZ. Knockdown of fascin1 expression suppresses the proliferation and metastasis of gastric cancer cells. Pathology 2009; 41(7): 655–660

    Article  CAS  PubMed  Google Scholar 

  23. Murray MY, Birkland TP, Howe JD, Rowan AD, Fidock M, Parks WC, Gavrilovic J. Macrophage migration and invasion is regulated by MMP10 expression. PLoS ONE 2013; 8(5): e63555

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Xie XM, Zhang ZY, Yang LH, Yang DL, Tang N, Zhao HY, Xu HT, Li QC, Wang EH. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers. Int J Oncol 2013; 43(5): 1636–1642

    CAS  PubMed  Google Scholar 

  25. Prunier C, Howe PH. Disabled-2 (Dab2) is required for transforming growth factor β-induced epithelial to mesenchymal transition (EMT). J Biol Chem 2005; 280(17): 17540–17548

    Article  CAS  PubMed  Google Scholar 

  26. Smith ER, Capo-chichi CD, He J, Smedberg JL, Yang DH, Prowse AH, Godwin AK, Hamilton TC, Xu XX. Disabled-2 mediates c-Fos suppression and the cell growth regulatory activity of retinoic acid in embryonic carcinoma cells. J Biol Chem 2001; 276(50): 47303–47310

    Article  CAS  PubMed  Google Scholar 

  27. Morris SM, Cooper JA. Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2. Traffic 2001; 2(2): 111–123

    Article  CAS  PubMed  Google Scholar 

  28. Xu XX, Yi T, Tang B, Lambeth JD. Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2. Oncogene 1998; 16(12): 1561–1569

    Article  CAS  PubMed  Google Scholar 

  29. Hocevar BA, Prunier C, Howe PH. Disabled-2 (Dab2) mediates transforming growth factor β (TGFβ)-stimulated fibronectin synthesis through TGFβ-activated kinase 1 and activation of the JNK pathway. J Biol Chem 2005; 280(27): 25920–25927

    Article  CAS  PubMed  Google Scholar 

  30. Huang C, Jacobson K, Schaller MD. MAP kinases and cell migration. J Cell Sci 2004; 117(20): 4619–4628

    Article  CAS  PubMed  Google Scholar 

  31. Hocevar BA, Smine A, Xu XX, Howe PH. The adaptor molecule disabled-2 links the transforming growth factor β receptors to the Smad pathway. EMBO J 2001; 20(11): 2789–2801

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China

    Yinyin Xie, Yuanliang Zhang, Lu Jiang, Mengmeng Zhang, Zhiwei Chen & Qiuhua Huang

  2. Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, 200240, China

    Dan Liu

Authors
  1. Yinyin Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuanliang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lu Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mengmeng Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhiwei Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Qiuhua Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qiuhua Huang.

Additional information

These authors contributed equally to this work.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xie, Y., Zhang, Y., Jiang, L. et al. Disabled homolog 2 is required for migration and invasion of prostate cancer cells. Front. Med. 9, 312–321 (2015). https://doi.org/10.1007/s11684-015-0401-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-015-0401-3

Keywords

Search

Navigation